๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Amifostine does not reduce the toxicity of the fludarabine and cyclophosphamide regimen in patients with chronic lymphocytic leukemia

โœ Scribed by Francis J. Giles; Gary Guangping Shi; Jorge E. Cortes; Deborah Thomas; Anna R. Keating; Hagop M. Kantarjian; Michael J. Keating; Susan M. O'Brien


Publisher
Springer
Year
2003
Tongue
English
Weight
189 KB
Volume
52
Category
Article
ISSN
0344-5704

No coin nor oath required. For personal study only.


๐Ÿ“œ SIMILAR VOLUMES


Fludarabine modulates composition and fu
โœ Franz Josef Gassner; Lukas Weiss; Roland Geisberger; Josefina Piรฑรณn Hofbauer; Al ๐Ÿ“‚ Article ๐Ÿ“… 2010 ๐Ÿ› Springer-Verlag ๐ŸŒ English โš– 509 KB

The combination of cytotoxic treatment with strategies for immune activation represents an attractive strategy for tumour therapy. Following reduction of high tumour burden by effective cytotoxic agents, two major immune-stimulating approaches are being pursued. First, innate immunity can be activat